Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: Increased frequency of other cancers and of cancers in multiple family members

Leukemia Research

Volumn 32, Issue 12, 2008, Pages 1820-1823

  Padmanabhan, Aruna ^a   Baker, Julie A ^a   Zirpoli, Gary ^a   Sait, Sheila N J ^a   Ford, Laurie A ^a   Moysich, Kirsten B ^a   Baer, Maria R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acute myeloid eukemia; Breast cancer; Myelodysplastic syndrome; Risk assessment; Therapy related

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; FEMALE; FISHER EXACT TEST; HUMAN; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; STUDENT T TEST;

BREAST NEOPLASMS; FAMILY; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; NUCLEAR FAMILY;

EID: 51649104876     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.03.032     Document Type: Article

References (22)

1. Howard R.A., Gilbert E.S., Chen B.E., et al. Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res Treat 105 (2007) 359-368
2. Smith R.E., Bryant J., DeCillis A., and Anderson S. National Surgical Adjuvant Breast and Bowel Project Experience. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 21 (2003) 1195-1204
3. Le Deley M.C., Suzan F., Cutuli B., et al. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. J Clin Oncol 25 (2007) 292-300
4. Hershman D., Neugut A.I., Jacobson J.S., et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 99 (2007) 196-205
5. Kaplan H.G., Malmgren J.A., and Atwood M. Leukemia incidence following primary breast carcinoma treatment. Cancer 101 (2004) 1529-1536
6. Diamandidou E., Buzdar A.U., Smith T.L., Frye D., Witjaksono M., and Hortobagyi G.N. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 14 (1996) 2722-2730
7. Carli P.M., Sgro C., Parchin-Geneste N., et al. Increase therapy-related leukemia secondary to breast cancer. Leukemia 14 (2000) 1014-1017
8. Curtis R.E., Boice Jr. J.D., Stovall M., et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326 (1992) 1745-1751
9. Patt D.A., Duan Z., Fang S., Hortobagyi G.N., and Giordano S.H. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. J Clin Oncol 25 25 (2007) 3871-3876 Sep 1
10. Pedersen-Bjergaard J., Andersen M.K., Christiansen D.H., and Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99 (2002) 1909-1912
11. Smith S.M., Le Beau M.M., Huo D., et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 102 (2003) 43-52
12. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103 (1985) 620-625
13. World Health Organization Classification of Tumours. In: Jaffee E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics. Tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France 89-91
14. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
15. Baker J.A., Beehler G.P., Sawant A.C., Jayaprakash V., McCann S.E., and Moysich K.B. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136 (2006) 166-171
16. Birch J.M., Alston R.D., McNally R.J., Evans D.G., Kelsey A.M., Harris M., et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20 (2001) 4621-4628
17. Olsen J.H., Hahnemann J.M., Børresen-Dale A.L., Brøndum-Nielsen K., Hammarström L., Kleinerman R., et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst 93 (2001) 121-127
18. Rauscher G.H., Sandler D.P., Poole C., et al. Family history of cancer and incidence of acute leukemia in adults. Am J Epidemiol 156 (2002) 517-526
19. Rauscher G.H., Sandler D.P., Poole C., et al. Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?. Cancer Epidemiol Biomarkers Prev 12 (2003) 289-294
20. Seedhouse C., and Russell N. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia. Br J Haematol 137 (2007) 513-529
21. Smith T.R., Levine E.A., Perrier N.D., Miller M.S., Freimanis R.I., Lohman K., et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12 (2003) 1200-1204
22. Hu Z., Ma H., Chen F., Wei Q., and Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14 (2005) 1810-1818